GHK-Cu will be voted on in a subsequent February 2027 meeting HHS has announced that GHK-Cu is expected to return to Category 1 (after being moved to Category 2 in September 2023), which would restore compounding access for injectable formulations. The dosing below draws from the per-component research and is reflected in the FDA review committee documents for each peptide, which aligns with PeptideFoxs previous research
These injections offer their own pros and cons
B12 is absorbed well from the fatty layer, so the vitamin reaches the bloodstream either way
When you lack an adequate amount of B12 in your system, it can lead to fatigue, weakness, and a compromised immune system
Animal studies show a more pronounced impact, where AOD9604 increased lipolysis and prevented fat accumulation, but these results dont fully translate to humans (example)
However, these injections work best when used alongside a healthy, personalized nutrition and fitness plan developed by our experienced nurse practitioners